Today's News

Vancouver, BC, December 6, 2022--(T-Net)--Vancouver-based Vistara Capital Partners announced today it has lead a $25 million capital raise in Australian-based VALD, a global health tech company, alongside existing investor Queensland Investment Corporation (QIC).

VALD's human measurement technology - delivered via an integrated hardware and software platform - is used almost ubiquitously among pro sports teams to monitor the performance and manage injuries of the world's highest paid athletes. More recently, it has been rapidly adopted by health professionals to help detect and rehabilitate a broad spectrum of musculoskeletal (MSK) conditions for patients of all ages and abilities.

Despite peak capital market conditions in 2021, VALD's co-founders chose not to pursue its planned IPO with the belief that remaining private would better serve their long-term vision.

During 2022, the Company sought an investment partner who could fund its organic growth and M&A ambitions, provide liquidity to dedicated pre-IPO funds no longer aligned with the Company's capital strategy, and manage dilution to ensure the founders retained significant ownership stakes and operational control.

"We worked collaboratively to tailor a creative solution to achieve these varied growth capital use cases, and are thrilled to partner with Laurie Malone, Sam James, and the VALD team in their mission to improve outcomes for MSK professionals and their patients", said Vistara in its announcement.

For Vistara Growth's full investment thesis, you can check out Why We Invested in Vald.

About Vistara Growth

Vistara Growth provides highly flexible growth debt and equity solutions to leading technology companies across North America. Founded, managed, and funded by seasoned technology finance and operating executives, "Vistara" (Sanskrit for "expansion") is focused on enabling growth for the ambitious entrepreneurs we invest in, our investors, our people, and the communities we operate in.